Cargando…

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis

Detalles Bibliográficos
Autores principales:	Heslet, L, Hald, R, Recke, C, Bangert, K, Uttenthal, LO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084268/ http://dx.doi.org/10.1186/cc7546

Ejemplares similares

Activated protein C–protein C inhibitor complex as a prognostic marker in sepsis
por: Heslet, Lars, et al.
Publicado: (2008)

High C-reactive protein and low cholesterol levels are prognostic marker in severe sepsis
por: Memis, D, et al.
Publicado: (2006)

Urinary and plasma NGAL levels reflect the severity of acute kidney injury
por: Bangert, K, et al.
Publicado: (2010)

Activated protein C in sepsis: an Indian experience
por: Abraham, B, et al.
Publicado: (2005)

C-Reactive protein and albumin as prognostic markers in intensive care
por: Mackay, A, et al.
Publicado: (2010)

Protein C in murine neonatal sepsis
por: Muchitsch, E, et al.
Publicado: (2005)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

C-reactive protein as an early marker of sepsis resolution: results from the Portuguese Community-acquired Sepsis Study (SACiUCI study)
por: Povoa, P, et al.
Publicado: (2011)

Risk/benefit analysis of activated protein C in patients with intra-abdominal sepsis
por: Borthwick, E, et al.
Publicado: (2007)

Activated protein C consumption and coagulation parameters in severe sepsis and septic shock
por: De La Torre-Prados, M, et al.
Publicado: (2014)

Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
por: Mohamed, H, et al.
Publicado: (2007)

Testing of anti-activated protein C antibodies in four drotrecogin alfa (activated) severe sepsis studies
por: Yan, S, et al.
Publicado: (2008)

Serum C-reactive protein concentration in early abdominal and pulmonary sepsis
por: Orati, JA, et al.
Publicado: (2013)

C1-esterase inhibitor (C1INH) implication in systemic inflammation in sepsis
por: Igonin, A, et al.
Publicado: (2010)

Efficiency diagnostic and advantages of procalcitonin and C-reactive protein in the early diagnosis of sepsis
por: De la Torre-Prados, M, et al.
Publicado: (2010)

Pancreatic stone protein as a novel marker for neonatal sepsis
por: Schlapbach, L, et al.
Publicado: (2012)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Role of procalcitonin and high-sensitivity C-reactive protein in sepsis: a prospective study
por: Das, S, et al.
Publicado: (2011)

Severe protein C deficiency association with organ dysfunction and mortality in patients with severe sepsis
por: Vail, M, et al.
Publicado: (2007)

Serum C-reactive protein levels in patients with sepsis varies according to the site of infection
por: Lobo, S, et al.
Publicado: (2005)

C-reactive protein and hemogram parameters for the nonsepsis SIRS and sepsis: what do they mean?
por: Gucyetmez, B, et al.
Publicado: (2015)

First experiences with protein C concentrate in adult patients with severe sepsis and septic shock associated to low protein C levels: a dose-finding study
por: Baratto, F, et al.
Publicado: (2005)

Compliment activity patterns in patients with sepsis after human purified C1-esterase inhibitor infusion
por: Igonin, A, et al.
Publicado: (2009)

Activated protein C: cost matters!
por: Dravid, T, et al.
Publicado: (2010)

Study of the effect of C1-esterase inhibitor administration to the sepsis pig model
por: Imahase, Hisashi, et al.
Publicado: (2013)

Serial change of C1 inhibitor in patients with sepsis: a preliminary report
por: Hirose, T, et al.
Publicado: (2015)

Surviving ratio of severe sepsis treated with activated protein C in one university intensive care unit during 2003–2006
por: Tokarz, A, et al.
Publicado: (2007)

Effects of recombinant surfactant protein C and elastase inhibitor on neutrophil apoptosis
por: Pravinkumar, E, et al.
Publicado: (2004)

Daily assay of procalcitonin, C-reactive protein and IL-6 roles in diagnosis and management of severe sepsis
por: Umbrello, M, et al.
Publicado: (2009)

Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008)

Effect of including procalcitonin and C-reactive protein in the Mortality in Emergency Department Sepsis risk prediction model
por: Lee, C, et al.
Publicado: (2011)

C-reactive protein ratio response patterns in pediatric sepsis: a cohort study - preliminary results
por: Soares Lanziotti, V, et al.
Publicado: (2015)

Thromboelastography during treatment with activated protein C
por: Panascia, E, et al.
Publicado: (2005)

Identification of cCMP binding and activated proteins
por: Wolfertstetter, Stefanie, et al.
Publicado: (2013)

Pharmacokinetic–pharmacodynamic analysis of human purified C1-esterase inhibitor in patients with sepsis
por: Dolzhenkova, L, et al.
Publicado: (2008)

Base excess and arterial lactate as early prognostic markers in severe sepsis patients
por: Silva, JM, et al.
Publicado: (2005)

C-reactive protein as a marker of septic shock and outcome in the intensive care unit
por: Theodorakopoulou, M, et al.
Publicado: (2005)

C-reactive protein as an early marker of healthcare-associated pneumonia outcome in cancer patients
por: Sarmet Cunha Farah Rabello, L, et al.
Publicado: (2015)

Age and number of organ dysfunctions are associated with early mortality in patients suffering from severe sepsis treated with recombinant human activated protein C
por: Vazquez de Anda, G, et al.
Publicado: (2004)

Lactate as a prognostic marker in patients with severe sepsis or septic shock admitted to the ICU
por: Rocha, LL, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ovr4s7jlg21ink1rkgqomqhesr